Targeting liposarcoma: unveiling molecular pathways and therapeutic opportunities
- PMID: 39723387
- PMCID: PMC11668776
- DOI: 10.3389/fonc.2024.1484027
Targeting liposarcoma: unveiling molecular pathways and therapeutic opportunities
Abstract
In recent years, an increasing number of studies have utilized molecular biology techniques to reveal important molecular heterogeneity among different subtypes of liposarcoma. Each subtype exhibits distinct genetic patterns and molecular pathways, which may serve as important targets for molecular therapy. In the present review, we focus on the molecular characteristics, molecular diagnostics, driver genes, and molecular mechanisms of liposarcoma. We also discuss the clinical research progress of related targeted therapies, with an aim to provide a reference and crucial insights for colleagues in the field.
Keywords: driver genes; liposarcoma; molecular pathogenesis; outlook; targeted therapy.
Copyright © 2024 Liu, Wang, Liu, Yan, Qiu and Zhou.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection.Cancers (Basel). 2024 Jan 8;16(2):271. doi: 10.3390/cancers16020271. Cancers (Basel). 2024. PMID: 38254762 Free PMC article. Review.
-
An overview on liposarcoma subtypes: Genetic alterations and recent advances in therapeutic strategies.J Mol Histol. 2024 Jun;55(3):227-240. doi: 10.1007/s10735-024-10195-4. Epub 2024 May 2. J Mol Histol. 2024. PMID: 38696048 Review.
-
Application of molecular biology to individualize therapy for patients with liposarcoma.Am Soc Clin Oncol Educ Book. 2015:213-8. doi: 10.14694/EdBook_AM.2015.35.213. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993159 Review.
-
Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.Cancer Res. 2007 Jul 15;67(14):6626-36. doi: 10.1158/0008-5472.CAN-07-0584. Cancer Res. 2007. PMID: 17638873
-
Deciphering the roles of non-coding RNAs in liposarcoma development: Challenges and opportunities for translational therapeutic advances.Noncoding RNA Res. 2024 Nov 15;11:73-90. doi: 10.1016/j.ncrna.2024.11.005. eCollection 2025 Apr. Noncoding RNA Res. 2024. PMID: 39736850 Free PMC article. Review.
Cited by
-
Histomorphological and molecular characteristics of liposarcoma (Review).Oncol Lett. 2025 Jul 21;30(4):454. doi: 10.3892/ol.2025.15200. eCollection 2025 Oct. Oncol Lett. 2025. PMID: 40747377 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources